Vertex Pharmaceuticals Inc. buy BiotechBee
Start price
07.09.22
/
70%
€285.85
Target price
31.12.25
€400.00
Performance (%)
10.34%
End price
05.05.23
€315.40
Summary
This prediction ended on 05.05.23 with a price of €315.40. The prediction had a final performance of 10.34%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.638% | 3.638% | 40.954% | 49.086% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
According to BiotechBee what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 400,0